Industry news from PTC Therapeutics
Category: Industry News
Type 1 Spinal Muscular Atrophy: Risdiplam (RG7916) Pivotal FIREFISH Study Demonstrated Statistically Significant Improvement in Infants
News from PTC therapeutics
New mobile scanner allows CT images of the head directly on the ICU ward
News from Siemens
Neurokinex Kids brings breakthrough therapies to children with Cerebral Palsy
Industry news from Neurokinex
EU approval of Mayzent® (siponimod) for adult patients with secondary progressive multiple sclerosis (SPMS) with active disease
News from Novartis on the EU approval of Mayzent (siponimod) for adult patients with SPMS with active disease
Phase II clinical trial of respiratory drug for treatment of Parkinson’s reveals promising results
News from the Cure Parkinson’s Trust
Ocrelizumab (Ocrevus®) accepted for use in PPMS within NHS Scotland
Industry news from Roche
Fremanezumab: Chronic and episodic migraine medication approved for use within NHS Scotland
Industry news from Teva Pharmaceuticals
ATAI Life Sciences partners to reduce the impact of concussion on and off the field
News from ATAI and Neuronasal
